Trials / Completed
CompletedNCT01289249
Meropenem Plasma Concentration Measurements at the Pediatric Medical Ward, Oslo University Hospital, Rikshospitalet
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (actual)
- Sponsor
- Oslo University Hospital · Academic / Other
- Sex
- All
- Age
- 3 Months – 18 Years
- Healthy volunteers
- Not accepted
Summary
The object of the study is to investigate whether all included patients receive treatment that is effective against all bacteria that are defined as sensitive to meropenem with the current treatment regimen. Will the investigators findings motivate routine monitoring of plasma concentrations in children receiving meropenem? Up to 50 patients will be included in the study, and all participants are children.
Conditions
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2014-01-01
- Completion
- 2014-01-01
- First posted
- 2011-02-03
- Last updated
- 2014-11-06
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT01289249. Inclusion in this directory is not an endorsement.